Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 49 entries
Sorted by: Best Match Show Resources per page
Prevalence of Intestinal Protozoa among Saudi Patients with Chronic Renal Failure: A Case-Control Study.

Journal of tropical medicine

Hawash YA, Dorgham LSh, Amir el-AM, Sharaf OF.
PMID: 26491455
J Trop Med. 2015;2015:563478. doi: 10.1155/2015/563478. Epub 2015 Sep 28.

It has been hypothesized that chronic renal failure (CRF) predisposes patients to infection with intestinal protozoa. We tested this hypothesis with a matched case-control study to determine the prevalence of these protozoa and their diarrhea associated symptoms among 50...

Cite
Hawash YA, Dorgham LSh, Amir el-AM, et al. Prevalence of Intestinal Protozoa among Saudi Patients with Chronic Renal Failure: A Case-Control Study. J Trop Med. 2015;2015:563478doi: 10.1155/2015/563478.
Hawash, Y. A., Dorgham, L. S. h., Amir, e. l. -. A. M., & Sharaf, O. F. (2015). Prevalence of Intestinal Protozoa among Saudi Patients with Chronic Renal Failure: A Case-Control Study. Journal of tropical medicine, 2015563478. https://doi.org/10.1155/2015/563478
Hawash, Yousry A, et al. "Prevalence of Intestinal Protozoa among Saudi Patients with Chronic Renal Failure: A Case-Control Study." Journal of tropical medicine vol. 2015 (2015): 563478. doi: https://doi.org/10.1155/2015/563478
Hawash YA, Dorgham LSh, Amir el-AM, Sharaf OF. Prevalence of Intestinal Protozoa among Saudi Patients with Chronic Renal Failure: A Case-Control Study. J Trop Med. 2015;2015:563478. doi: 10.1155/2015/563478. Epub 2015 Sep 28. PMID: 26491455; PMCID: PMC4600868.
Copy Download .nbib Format: NLM
Caroli Disease: A Presentation of Acute Pancreatitis and Cholangitis.

Cureus

Khan MZ, Kichloo A, El-Amir Z, Shah Zaib M, Wani F.
PMID: 32789075
Cureus. 2020 Jul 11;12(7):e9135. doi: 10.7759/cureus.9135.

Caroli disease is a rare congenital disorder resulting from the dilation of large intrahepatic bile ducts. Patients affected with Caroli disease are at increased risk of complications resulting from bile stasis and stone formation. We report the case of...

Cite
Khan MZ, Kichloo A, El-Amir Z, et al. Caroli Disease: A Presentation of Acute Pancreatitis and Cholangitis. Cureus. 2020;12(7):e9135doi: 10.7759/cureus.9135.
Khan, M. Z., Kichloo, A., El-Amir, Z., Shah Zaib, M., & Wani, F. (2020). Caroli Disease: A Presentation of Acute Pancreatitis and Cholangitis. Cureus, 12(7), e9135. https://doi.org/10.7759/cureus.9135
Khan, Muhammad Z, et al. "Caroli Disease: A Presentation of Acute Pancreatitis and Cholangitis." Cureus vol. 12,7 (2020): e9135. doi: https://doi.org/10.7759/cureus.9135
Khan MZ, Kichloo A, El-Amir Z, Shah Zaib M, Wani F. Caroli Disease: A Presentation of Acute Pancreatitis and Cholangitis. Cureus. 2020 Jul 11;12(7):e9135. doi: 10.7759/cureus.9135. PMID: 32789075; PMCID: PMC7417087.
Copy Download .nbib Format: NLM
Hospitalizations for ketoacidosis in type 1 diabetes mellitus, 2008 to 2018.

Proceedings (Baylor University. Medical Center)

Kichloo A, El-Amir Z, Wani F, Shaka H.
PMID: 34970023
Proc (Bayl Univ Med Cent). 2021 Oct 01;35(1):1-5. doi: 10.1080/08998280.2021.1978741. eCollection 2022.

The objective of this study was to characterize epidemiological trends, outcomes in hospitalized patients, and the disease burden of hospitalizations for diabetic ketoacidosis (DKA) in patients with type 1 diabetes mellitus (T1DM). This was a retrospective interrupted trends study...

Cite
Kichloo A, El-Amir Z, Wani F, et al. Hospitalizations for ketoacidosis in type 1 diabetes mellitus, 2008 to 2018. Proc (Bayl Univ Med Cent). 2021;35(1):1-5doi: 10.1080/08998280.2021.1978741.
Kichloo, A., El-Amir, Z., Wani, F., & Shaka, H. (2022). Hospitalizations for ketoacidosis in type 1 diabetes mellitus, 2008 to 2018. Proceedings (Baylor University. Medical Center), 35(1), 1-5. https://doi.org/10.1080/08998280.2021.1978741
Kichloo, Asim, et al. "Hospitalizations for ketoacidosis in type 1 diabetes mellitus, 2008 to 2018." Proceedings (Baylor University. Medical Center) vol. 35,1 (2022): 1-5. doi: https://doi.org/10.1080/08998280.2021.1978741
Kichloo A, El-Amir Z, Wani F, Shaka H. Hospitalizations for ketoacidosis in type 1 diabetes mellitus, 2008 to 2018. Proc (Bayl Univ Med Cent). 2021 Oct 01;35(1):1-5. doi: 10.1080/08998280.2021.1978741. eCollection 2022. PMID: 34970023; PMCID: PMC8682866.
Copy Download .nbib Format: NLM
Utilization of extracorporeal membrane oxygenation during the COVID-19 pandemic.

World journal of critical care medicine

Kichloo A, Kumar A, Amir R, Aljadah M, Farooqi N, Albosta M, Singh J, Jamal S, El-Amir Z, Kichloo A, Lone N.
PMID: 33505868
World J Crit Care Med. 2021 Jan 09;10(1):1-11. doi: 10.5492/wjccm.v10.i1.1. eCollection 2021 Jan 09.

The ongoing outbreak of severe acute respiratory syndrome coronavirus-2 [SARS-CoV-2, or coronavirus disease 2019 (COVID-19)] was declared a pandemic by the World Health Organization on March 11, 2020. Worldwide, more than 65 million people have been infected with this...

Cite
Kichloo A, Kumar A, Amir R, et al. Utilization of extracorporeal membrane oxygenation during the COVID-19 pandemic. World J Crit Care Med. 2021;10(1):1-11doi: 10.5492/wjccm.v10.i1.1.
Kichloo, A., Kumar, A., Amir, R., Aljadah, M., Farooqi, N., Albosta, M., Singh, J., Jamal, S., El-Amir, Z., Kichloo, A., & Lone, N. (2021). Utilization of extracorporeal membrane oxygenation during the COVID-19 pandemic. World journal of critical care medicine, 10(1), 1-11. https://doi.org/10.5492/wjccm.v10.i1.1
Kichloo, Asim, et al. "Utilization of extracorporeal membrane oxygenation during the COVID-19 pandemic." World journal of critical care medicine vol. 10,1 (2021): 1-11. doi: https://doi.org/10.5492/wjccm.v10.i1.1
Kichloo A, Kumar A, Amir R, Aljadah M, Farooqi N, Albosta M, Singh J, Jamal S, El-Amir Z, Kichloo A, Lone N. Utilization of extracorporeal membrane oxygenation during the COVID-19 pandemic. World J Crit Care Med. 2021 Jan 09;10(1):1-11. doi: 10.5492/wjccm.v10.i1.1. eCollection 2021 Jan 09. PMID: 33505868; PMCID: PMC7805254.
Copy Download .nbib Format: NLM
The potential use of serum interleukin-21 as biomarker for lupus nephritis activity compared to cytokines of the tumor necrosis factor (TNF) family.

Lupus

Shater H, Fawzy M, Farid A, El-Amir A, Fouad S, Madbouly N.
PMID: 34978958
Lupus. 2022 Jan 03;9612033211063794. doi: 10.1177/09612033211063794. Epub 2022 Jan 03.

OBJECTIVE: Lupus nephritis (LN) is a significant consequence of systemic lupus erythematosus (SLE). To the best of our knowledge, this is the first work that focuses on evaluation of serum interleukin (IL-) 21 as a diagnostic biomarker of LN...

Cite
Shater H, Fawzy M, Farid A, et al. The potential use of serum interleukin-21 as biomarker for lupus nephritis activity compared to cytokines of the tumor necrosis factor (TNF) family. Lupus. 2022;9612033211063794doi: 10.1177/09612033211063794.
Shater, H., Fawzy, M., Farid, A., El-Amir, A., Fouad, S., & Madbouly, N. (2022). The potential use of serum interleukin-21 as biomarker for lupus nephritis activity compared to cytokines of the tumor necrosis factor (TNF) family. Lupus, 9612033211063794. https://doi.org/10.1177/09612033211063794
Shater, Hend, et al. "The potential use of serum interleukin-21 as biomarker for lupus nephritis activity compared to cytokines of the tumor necrosis factor (TNF) family." Lupus vol. (2022): 9612033211063794. doi: https://doi.org/10.1177/09612033211063794
Shater H, Fawzy M, Farid A, El-Amir A, Fouad S, Madbouly N. The potential use of serum interleukin-21 as biomarker for lupus nephritis activity compared to cytokines of the tumor necrosis factor (TNF) family. Lupus. 2022 Jan 03;9612033211063794. doi: 10.1177/09612033211063794. Epub 2022 Jan 03. PMID: 34978958.
Copy Download .nbib Format: NLM
Rate and predictors of 30-day readmission for .

Annals of medicine

Kichloo A, El-Amir Z, Dahiya DS, Al-Haddad M, Singh J, Singh G, Corpuz C, Shaka H.
PMID: 34989297
Ann Med. 2022 Dec;54(1):150-158. doi: 10.1080/07853890.2021.2023211.

METHODS: We conducted a retrospective study of the Nationwide Readmissions Database to identify adult hospitalizations with a principal diagnosis of CDE for 2018. Individuals

Cite
Kichloo A, El-Amir Z, Dahiya DS, et al. Rate and predictors of 30-day readmission for . Ann Med. 2022;54(1):150-158doi: 10.1080/07853890.2021.2023211.
Kichloo, A., El-Amir, Z., Dahiya, D. S., Al-Haddad, M., Singh, J., Singh, G., Corpuz, C., & Shaka, H. (2022). Rate and predictors of 30-day readmission for . Annals of medicine, 54(1), 150-158. https://doi.org/10.1080/07853890.2021.2023211
Kichloo, Asim, et al. "Rate and predictors of 30-day readmission for ." Annals of medicine vol. 54,1 (2022): 150-158. doi: https://doi.org/10.1080/07853890.2021.2023211
Kichloo A, El-Amir Z, Dahiya DS, Al-Haddad M, Singh J, Singh G, Corpuz C, Shaka H. Rate and predictors of 30-day readmission for . Ann Med. 2022 Dec;54(1):150-158. doi: 10.1080/07853890.2021.2023211. PMID: 34989297; PMCID: PMC8741240.
Copy Download .nbib Format: NLM
Rate and predictors of 30-day readmission for .

Annals of medicine

Kichloo A, El-Amir Z, Dahiya DS, Al-Haddad M, Singh J, Singh G, Corpuz C, Shaka H.
PMID: 34989297
Ann Med. 2022 Dec;54(1):150-158. doi: 10.1080/07853890.2021.2023211.

METHODS: We conducted a retrospective study of the Nationwide Readmissions Database to identify adult hospitalizations with a principal diagnosis of CDE for 2018. Individuals

Cite
Kichloo A, El-Amir Z, Dahiya DS, et al. Rate and predictors of 30-day readmission for . Ann Med. 2022;54(1):150-158doi: 10.1080/07853890.2021.2023211.
Kichloo, A., El-Amir, Z., Dahiya, D. S., Al-Haddad, M., Singh, J., Singh, G., Corpuz, C., & Shaka, H. (2022). Rate and predictors of 30-day readmission for . Annals of medicine, 54(1), 150-158. https://doi.org/10.1080/07853890.2021.2023211
Kichloo, Asim, et al. "Rate and predictors of 30-day readmission for ." Annals of medicine vol. 54,1 (2022): 150-158. doi: https://doi.org/10.1080/07853890.2021.2023211
Kichloo A, El-Amir Z, Dahiya DS, Al-Haddad M, Singh J, Singh G, Corpuz C, Shaka H. Rate and predictors of 30-day readmission for . Ann Med. 2022 Dec;54(1):150-158. doi: 10.1080/07853890.2021.2023211. PMID: 34989297.
Copy Download .nbib Format: NLM
Sweat testing in the modern era: A national survey of sweat testing practice in the Republic of Ireland.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Maguire B, Blake O, Boran G, Borovickova I, Abdelfadil S, Murray C, Elnazir B, Linnane B.
PMID: 34620573
J Cyst Fibros. 2021 Oct 04; doi: 10.1016/j.jcf.2021.09.012. Epub 2021 Oct 04.

BACKGROUND: The sweat test has been the "gold standard" diagnostic test for cystic fibrosis for more than 40 years. We hypothesized that there would be a change in the pattern of sweat testing in Ireland since the introduction of...

Cite
Maguire B, Blake O, Boran G, et al. Sweat testing in the modern era: A national survey of sweat testing practice in the Republic of Ireland. J Cyst Fibros. 2021;doi: 10.1016/j.jcf.2021.09.012.
Maguire, B., Blake, O., Boran, G., Borovickova, I., Abdelfadil, S., Murray, C., Elnazir, B., & Linnane, B. (2021). Sweat testing in the modern era: A national survey of sweat testing practice in the Republic of Ireland. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, . https://doi.org/10.1016/j.jcf.2021.09.012
Maguire, Barrie, et al. "Sweat testing in the modern era: A national survey of sweat testing practice in the Republic of Ireland." Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society vol. (2021). doi: https://doi.org/10.1016/j.jcf.2021.09.012
Maguire B, Blake O, Boran G, Borovickova I, Abdelfadil S, Murray C, Elnazir B, Linnane B. Sweat testing in the modern era: A national survey of sweat testing practice in the Republic of Ireland. J Cyst Fibros. 2021 Oct 04; doi: 10.1016/j.jcf.2021.09.012. Epub 2021 Oct 04. PMID: 34620573.
Copy Download .nbib Format: NLM
Association of hypocalcemia with in-hospital mortality and complications in patients with acute pulmonary embolism: results from the 2017 Nationwide Inpatient Sample.

BMC pulmonary medicine

Murthi M, Shaka H, El-Amir Z, Velagapudi S, Jamil A, Wani F, Atluri R, Kumar A, Kichloo A.
PMID: 34895211
BMC Pulm Med. 2021 Dec 11;21(1):410. doi: 10.1186/s12890-021-01784-0.

BACKGROUND: Acute pulmonary embolism (PE) is a common cause for hospitalization associated with significant mortality and morbidity. Disorders of calcium metabolism are a frequently encountered medical problem. The effect of hypocalcemia is not well defined on the outcomes of...

Cite
Murthi M, Shaka H, El-Amir Z, et al. Association of hypocalcemia with in-hospital mortality and complications in patients with acute pulmonary embolism: results from the 2017 Nationwide Inpatient Sample. BMC Pulm Med. 2021;21(1):410doi: 10.1186/s12890-021-01784-0.
Murthi, M., Shaka, H., El-Amir, Z., Velagapudi, S., Jamil, A., Wani, F., Atluri, R., Kumar, A., & Kichloo, A. (2021). Association of hypocalcemia with in-hospital mortality and complications in patients with acute pulmonary embolism: results from the 2017 Nationwide Inpatient Sample. BMC pulmonary medicine, 21(1), 410. https://doi.org/10.1186/s12890-021-01784-0
Murthi, Mukunthan, et al. "Association of hypocalcemia with in-hospital mortality and complications in patients with acute pulmonary embolism: results from the 2017 Nationwide Inpatient Sample." BMC pulmonary medicine vol. 21,1 (2021): 410. doi: https://doi.org/10.1186/s12890-021-01784-0
Murthi M, Shaka H, El-Amir Z, Velagapudi S, Jamil A, Wani F, Atluri R, Kumar A, Kichloo A. Association of hypocalcemia with in-hospital mortality and complications in patients with acute pulmonary embolism: results from the 2017 Nationwide Inpatient Sample. BMC Pulm Med. 2021 Dec 11;21(1):410. doi: 10.1186/s12890-021-01784-0. PMID: 34895211; PMCID: PMC8665606.
Copy Download .nbib Format: NLM
Hospitalizations for ketoacidosis in type 1 diabetes mellitus, 2008 to 2018.

Proceedings (Baylor University. Medical Center)

Kichloo A, El-Amir Z, Wani F, Shaka H.
PMID: 34970023
Proc (Bayl Univ Med Cent). 2021 Oct 01;35(1):1-5. doi: 10.1080/08998280.2021.1978741. eCollection 2022.

The objective of this study was to characterize epidemiological trends, outcomes in hospitalized patients, and the disease burden of hospitalizations for diabetic ketoacidosis (DKA) in patients with type 1 diabetes mellitus (T1DM). This was a retrospective interrupted trends study...

Cite
Kichloo A, El-Amir Z, Wani F, et al. Hospitalizations for ketoacidosis in type 1 diabetes mellitus, 2008 to 2018. Proc (Bayl Univ Med Cent). 2021;35(1):1-5doi: 10.1080/08998280.2021.1978741.
Kichloo, A., El-Amir, Z., Wani, F., & Shaka, H. (2022). Hospitalizations for ketoacidosis in type 1 diabetes mellitus, 2008 to 2018. Proceedings (Baylor University. Medical Center), 35(1), 1-5. https://doi.org/10.1080/08998280.2021.1978741
Kichloo, Asim, et al. "Hospitalizations for ketoacidosis in type 1 diabetes mellitus, 2008 to 2018." Proceedings (Baylor University. Medical Center) vol. 35,1 (2022): 1-5. doi: https://doi.org/10.1080/08998280.2021.1978741
Kichloo A, El-Amir Z, Wani F, Shaka H. Hospitalizations for ketoacidosis in type 1 diabetes mellitus, 2008 to 2018. Proc (Bayl Univ Med Cent). 2021 Oct 01;35(1):1-5. doi: 10.1080/08998280.2021.1978741. eCollection 2022. PMID: 34970023; PMCID: PMC8682866.
Copy Download .nbib Format: NLM
Thirty-Day Hospital Readmissions for Acute Gout in the United States: Analysis of the Nationwide Readmission Database.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases

Kichloo A, Edigin E, Jamal S, El-Amir Z, Aucar MI, Wani F, Eseaton PO, Annapureddy N, Cabling MG, Manadan AM.
PMID: 34176884
J Clin Rheumatol. 2021 Jun 26; doi: 10.1097/RHU.0000000000001761. Epub 2021 Jun 26.

BACKGROUND/OBJECTIVE: The aims of this study were to describe the rates and characteristics of nonelective 30-day readmission among adult patients hospitalized for acute gout and to assess predictors of readmission.METHODS: We analyzed the 2017 Nationwide Readmission Database. Gout hospitalizations...

Cite
Kichloo A, Edigin E, Jamal S, et al. Thirty-Day Hospital Readmissions for Acute Gout in the United States: Analysis of the Nationwide Readmission Database. J Clin Rheumatol. 2021;doi: 10.1097/RHU.0000000000001761.
Kichloo, A., Edigin, E., Jamal, S., El-Amir, Z., Aucar, M. I., Wani, F., Eseaton, P. O., Annapureddy, N., Cabling, M. G., & Manadan, A. M. (2021). Thirty-Day Hospital Readmissions for Acute Gout in the United States: Analysis of the Nationwide Readmission Database. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, . https://doi.org/10.1097/RHU.0000000000001761
Kichloo, Asim, et al. "Thirty-Day Hospital Readmissions for Acute Gout in the United States: Analysis of the Nationwide Readmission Database." Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases vol. (2021). doi: https://doi.org/10.1097/RHU.0000000000001761
Kichloo A, Edigin E, Jamal S, El-Amir Z, Aucar MI, Wani F, Eseaton PO, Annapureddy N, Cabling MG, Manadan AM. Thirty-Day Hospital Readmissions for Acute Gout in the United States: Analysis of the Nationwide Readmission Database. J Clin Rheumatol. 2021 Jun 26; doi: 10.1097/RHU.0000000000001761. Epub 2021 Jun 26. PMID: 34176884.
Copy Download .nbib Format: NLM
National trends in hospitalizations of atopic dermatitis adult patients: A 21-year longitudinal United States population-based study.

Journal of the American Academy of Dermatology

Edigin E, Kichloo A, El-Amir Z, Wani F, Eseaton PO, Shaka H.
PMID: 34252469
J Am Acad Dermatol. 2021 Jul 10; doi: 10.1016/j.jaad.2021.06.882. Epub 2021 Jul 10.

No abstract available.

Cite
Edigin E, Kichloo A, El-Amir Z, et al. National trends in hospitalizations of atopic dermatitis adult patients: A 21-year longitudinal United States population-based study. J Am Acad Dermatol. 2021;doi: 10.1016/j.jaad.2021.06.882.
Edigin, E., Kichloo, A., El-Amir, Z., Wani, F., Eseaton, P. O., & Shaka, H. (2021). National trends in hospitalizations of atopic dermatitis adult patients: A 21-year longitudinal United States population-based study. Journal of the American Academy of Dermatology, . https://doi.org/10.1016/j.jaad.2021.06.882
Edigin, Ehizogie, et al. "National trends in hospitalizations of atopic dermatitis adult patients: A 21-year longitudinal United States population-based study." Journal of the American Academy of Dermatology vol. (2021). doi: https://doi.org/10.1016/j.jaad.2021.06.882
Edigin E, Kichloo A, El-Amir Z, Wani F, Eseaton PO, Shaka H. National trends in hospitalizations of atopic dermatitis adult patients: A 21-year longitudinal United States population-based study. J Am Acad Dermatol. 2021 Jul 10; doi: 10.1016/j.jaad.2021.06.882. Epub 2021 Jul 10. PMID: 34252469.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 49 entries